Preview

Koloproktologia

Advanced search

CLINICAL GUIDELINES Diverticular disease (57.2, 57.3), adults

https://doi.org/10.33878/2073-7556-2024-23-2-10-27

Abstract

.

About the Authors

Yu. A. Shelygin
Ryzhikh National Medical Research Center of Coloproctology; Russian Medical Academy of Continuous Professional Education
Russian Federation

Salyama Adilya str., 2, Moscow, 123423, Russia

Barrikadnaya st., 2/1-1, Moscow, 125993, Russia



V. T. Ivashkin
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation

Trubetskaya st., 8, bld. 2, Moscow, 119991, Russia 



S. I. Achkasov
Ryzhikh National Medical Research Center of Coloproctology; Russian Medical Academy of Continuous Professional Education
Russian Federation

Salyama Adilya st., 2, Moscow, 123423, Russia 

Barrikadnaya st., 2/1-1, Moscow, 125993, Russia



A. I. Moskalev
Ryzhikh National Medical Research Center of Coloproctology
Russian Federation

Salyama Adilya st., 2, Moscow, 123423, Russia 



V. M. Тimerbulatov
Bashkir State Medical University
Russian Federation

Lenin st., 3, Republic of Bashkortostan, Ufa, 450008, Russia 



A. V. Sazhin
Pirogov Russian National Research Medical University
Russian Federation

Ostrovityanova st., 1, Moscow, 117321, Russia 



S. G. Shapovalyants
Pirogov Russian National Research Medical University
Russian Federation

Ostrovityanova st., 1, Moscow, 117321, Russia



O. Y. Karpukhin
Kazan State Medical University
Russian Federation

Butlerova st., 49, Kazan, 420012, Russia 



N. V. Kostenko
Astrakhan State Medical University
Russian Federation

Bakinskaya st., 121, Astrakhan, 414000, Russia 



N. N. Кorotkikh
Voronezh State Medical University named after N.N. Burdenko of the Ministry of Health of the Russian Federation
Russian Federation

Studencheskaya st., 10, Voronezh, 394036, Russia 



I. V. Zarodnyuk
Ryzhikh National Medical Research Center of Coloproctology
Russian Federation

Salyama Adilya st., 2, Moscow, 123423, Russia 



J. L. Trubacheva
Ryzhikh National Medical Research Center of Coloproctology
Russian Federation

Salyama Adilya st., 2, Moscow, 123423, Russia 



V. V. Veselov
Ryzhikh National Medical Research Center of Coloproctology; Russian Medical Academy of Continuous Professional Education
Russian Federation

Salyama Adilya st., 2, Moscow, 123423, Russia 

Barrikadnaya st., 2/1-1, Moscow, 125993, Russia 



A. A. Likutov
Ryzhikh National Medical Research Center of Coloproctology; Russian Medical Academy of Continuous Professional Education
Russian Federation

Salyama Adilya st., 2, Moscow, 123423, Russia 

Barrikadnaya st., 2/1-1, Moscow, 125993, Russia 



V. N. Kashnikov
Ryzhikh National Medical Research Center of Coloproctology
Russian Federation

Salyama Adilya st., 2, Moscow, 123423, Russia 



S. A. Frolov
Ryzhikh National Medical Research Center of Coloproctology; Pirogov Russian National Research Medical University
Russian Federation

Salyama Adilya st., 2, Moscow, 123423, Russia 

Ostrovityanova st., 1, Moscow, 117321, Russia 



P. A. Yartsev
Sklifosovsky Research Institute for Emergency Medicine of the Moscow Department of Health
Russian Federation

B. Sukharevskaya pl., 3, Moscow, 107045, Russia 



I. D. Loranskaya
Russian Medical Academy of Continuous Professional Education
Russian Federation

Barrikadnaya st., 2/1-1, Moscow, 125993, Russia



B. A. Vykova
Ryzhikh National Medical Research Center of Coloproctology
Russian Federation

Salyama Adilya st., 2, Moscow, 123423, Russia 



O. S. Shifrin
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation

Trubetskaya st., 8, bld. 2, Moscow, 119991, Russia 



E. A. Poluektova
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation

Trubetskaya st., 8, bld. 2, Moscow, 119991, Russia 



Z. A. Mamieva
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation

Trubetskaya st., 8, bld. 2, Moscow, 119991, Russia 



A. I. Ulyanin
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation

Trubetskaya st., 8, bld. 2, Moscow, 119991, Russia 



T. V. Shkurko
Ryzhikh National Medical Research Center of Coloproctology
Russian Federation

Salyama Adilya st., 2, Moscow, 123423, Russia 



References

1. Shelygin Yu.A., Blagodarny L.A. Handbook of coloproctology. M.: Publishing house “Litterra”. 2012; 608 p. (in Russ.).

2. Nigri G, Petrucciani N, Giannini G, et al. Giant colonic diverticulum: clinical presentation, diagnosis and treatment: systematic review of 166 cases. World J Gastroenterol. 2015;21(1):360–368. doi: 10.3748/wjg.v21.i1.360

3. Painter NS, Burkitt DP. Diverticular disease of the colon, a 20th century problem. Clin Gastroenterol. 1975 Jan;4(1):3–21.

4. Collins D, Winter DC. Modern concepts in diverticular disease. J Clin Gastroenterol. 2015;49(5):358–369. doi: 10.1097/MCG.0000000000000308

5. Reichert MC, Lammert F. The genetic epidemiology of diverticulosis and diverticular disease: Emerging evidence. United European Gastroenterol J. 2015 Oct;3(5):409–18. doi: 10.1177/2050640615576676 PMID: 26535118; PMCID: PMC4625748.

6. Imaeda H, Hibi T. The Burden of Diverticular Disease and Its Complications: West versus East. Inflamm Intest Dis. 2018;3(2):61–68. doi: 10.1159/000492178

7. Piscopo N, Ellul P. Diverticular Disease: A Review on Pathophysiology and Recent Evidence. Ulster Med J. 2020;89(2):83–88.

8. Rezapour M, Ali S, Stollman N. Diverticular Disease: An Update on Pathogenesis and Management. Gut Liver. 2018 Mar 15;12(2):125–132. doi: 10.5009/gnl16552 PMID: 28494576; PMCID: PMC5832336.

9. Meyers MA, Alonozo DR, Gray GF, et al. Pathogenosis of bleeding colonic diverticulosis. Gastroenterology. 1976;71:577–583.

10. Wess L, Eastwood MA, Wess TJ, et al. Cross linking of collagen is increased in colonic diverticulosis. Gut. 1995;37(1):91–94. doi: 10.1136/gut.37.1.91

11. West BA. The pathology of diverticulosis: classical concepts and mucosal changes in diverticula. J Clin Gastroenterol. 2006;40 Suppl 3:S126–S131. doi: 10.1097/01.mcg.0000225508.90417.07

12. Violi A, Cambiè G, Miraglia C, et al. Epidemiology and risk factors for diverticular disease. Acta Biomed. 2018 Dec 17;89(9-S):107–112. doi: 10.23750/abm.v89i9-S.7924 PMID: 30561403; PMCID: PMC6502189.

13. Tursi A, Elisei W. Role of Inflammation in the Pathogenesis of Diverticular Disease. Mediators Inflamm. 2019;2019:8328490. Published 2019 Mar 14. doi: 10.1155/2019/8328490

14. Tănase I, Păun S, Stoica B, et al. Epidemiology of diverticular disease — systematic review of the literature. Chirurgia (Bucur). 2015;110(1):9–14.

15. Shelygin Yu.A., Achkasov S.I., Moskalev A.I. Classification of diverticular disease. Koloproktologia. 2014;4(50):5–13. (in Russ.).

16. Hinchey EJ, Schaal PGH, Richards GK. Treatment of perforated diverticular disease of the colon. Adv Surg. 1978;12:85–109.

17. Hansen O, Stock W. Prophylaktische operation bei der divertikelkrankheit des kolons — stufenkonzept durch exakte stadieinteilung. Langenbecks Arch Chir (Suppl II). 1999:1257–60.

18. Schreyer AG, Layer G. German Society of Digestive and Metabolic Diseases (DGVS) as well as the German Society of General and Visceral Surgery (DGAV) in collaboration with the German Radiology Society (DRG). S2k Guidlines for Diverticular Disease and Diverticulitis: Diagnosis, Classification, and Therapy for the Radiologist. Rofo. 2015;187(8):676–684. doi: 10.1055/s-0034-1399526

19. Bolikhov K.V. Acute inflammatory complications of diverticular colon disease (clinic, diagnosis, treatment). Abstract of the dissertation of the Candidate of Medical Sciences, M. 2006; 30 p. (in Russ.).

20. Tursi A, Papa A, Danese S. Review article: the pathophysiology and medical management of diverticulosis and diverticular disease of the colon. Aliment Pharmacol Ther. 2015;42(6):664–684. doi: 10.1111/apt.13322

21. Moskalev A.I. Clinical and morphofunctional parallels in chronic complications of diverticular disease. Abstract of dissertation of the Candidate of Medical Sciences. M., 2007. 29 p. (in Russ.).

22. Strate LL, Morris AM. Epidemiology, Pathophysiology, and Treatment of Diverticulitis. Gastroenterology. 2019;156(5):1282–1298.e1. doi: 10.1053/j.gastro.2018.12.033

23. Aune D, Sen A, Leitzmann MF, et al. Body mass index and physical activity and the risk of diverticular disease: a systematic review and meta-analysis of prospective studies. Eur J Nutr. 2017;56(8):2423–2438. doi: 10.1007/s00394-017-1443-x

24. Biondo S, Borao JL, Kreisler E, et al. Recurrence and virulence of colonic diverticulitis in immunocompromised patients. Am J Surg. 2012;204(2):172–179. doi: 10.1016/j.amjsurg.2011.09.027

25. Böhm SK, Kruis W. Lifestyle and other risk factors for diverticulitis. Minerva Gastroenterol Dietol. 2017;63(2):110–118. doi: 10.23736/S1121-421X.17.02371-6

26. Bolkenstein HE, van de Wall BJM, Consten ECJ, et al. Risk factors for complicated diverticulitis: systematic review and meta-analysis. Int J Colorectal Dis. 2017;32(10):1375–1383. doi: 10.1007/s00384-017-2872-y

27. van Dijk ST, Bos K, de Boer MGJ, et al. A systematic review and meta-analysis of outpatient treatment for acute diverticulitis. Int J Colorectal Dis. 2018;33(5):505–512. doi: 10.1007/s00384-018-3015-9

28. Tan JP, Barazanchi AW, Singh PP, et al. Predictors of acute diverticulitis severity: A systematic review. Int J Surg. 2016 Feb;26:43–52. doi: 10.1016/j.ijsu.2016.01.005 Epub 2016 Jan 9.

29. You H, Sweeny A, Cooper ML, et al. The management of diverticulitis: a review of the guidelines. Med J Aust. 2019;211(9):421–427. doi: 10.5694/mja2.5027

30. Thorisson A, Smedh K, Torkzad MR, et al. CT imaging for prediction of complications and recurrence in acute uncomplicated diverticulitis. Int J Colorectal Dis. 2016 Feb;31(2):451–7. doi: 10.1007/s00384-015-2423-3 Epub 2015 Oct 21.

31. Balk EM, Adam GP, Bhuma MR, et al. Diagnostic Imaging and Medical Management of Acute Left-Sided Colonic Diverticulitis: A Systematic Review. Ann Intern Med. 2022;175(3):379–387. doi: 10.7326/M21-1645

32. Heverhagen JT, Sitter H, Zielke A, et al. Prospective evaluation of the value of magnetic resonance imaging in suspected acute sigmoid diverticulitis. Dis Colon Rectum. 2008;51(12):1810–1815. doi: 10.1007/s10350-008-9330-4

33. Cirocchi R, Grassi V, Cavaliere D, et al. New Trends in Acute Management of Colonic Diverticular Bleeding: A Systematic Review. Medicine (Baltimore). 2015 Nov;94(44):e1710. doi: 10.1097/MD.0000000000001710

34. Lahat A, Yanai H, Menachem Y, et al. The feasibility and risk of early colonoscopy in acute diverticulitis: a prospective controlled study. Endoscopy. 2007 Jun;39(6):521–524.

35. Chen CY, Wu CC, Jao SW, et al. Colonic diverticular bleeding with comorbid diseases may need elective colectomy. J Gastrointest Surg. 2009;13(3):516–520.

36. Efremova I, Maslennikov R, Poluektova E, et al. Epidemiology of small intestinal bacterial overgrowth. World J Gastroenterol. 2023;29(22):3400–3421. doi: 10.3748/wjg.v29.i22.3400

37. Tursi A, Brandimarte G, Giorgetti GM, et al. Assessment of small intestinal bacterial overgrowth in uncomplicated acute diverticulitis of the colon. World J Gastroenterol. 2005;11(18):2773–2776. doi: 10.3748/wjg.v11.i18.2773

38. Carabotti M, Annibale B, Severi C, et al. Role of Fiber in Symptomatic Uncomplicated Diverticular Disease: A Systematic Review. Nutrients. 2017;9(2):161. Published 2017 Feb 20. doi: 10.3390/nu9020161

39. Lahner E, Bellisario C, Hassan C, et al. Probiotics in the Treatment of Diverticular Disease. A Systematic Review. J Gastrointestin Liver Dis. 2016;25(1):79–86. doi: 10.15403/jgld.2014.1121.251.srw

40. Pietrzak AM, Dziki A, Banasiewicz T, et al. Cyclic rifaximin therapy effectively prevents the recurrence of symptoms after exacerbation of symptomatic uncomplicated diverticular disease: a retrospective study. Prz Gastroenterol. 2019;14(1):69–78. doi: 10.5114/pg.2019.83428

41. Moniuszko A, Rydzewska G. The effect of cyclic rifaximin therapy on symptoms of diverticular disease from the perspective of the gastroenterology outpatient clinic: a «real-life» study. Prz Gastroenterol. 2017;12(2):145–151. doi: 10.5114/pg.2017.68167

42. Festa V, Spila Alegiani S, Chiesara F, et al. Retrospective comparison of long-term ten-day/month rifaximin or mesalazine in prevention of relapse in acute diverticulitis. Eur Rev Med Pharmacol Sci. 2017;21(6):1397–1404.

43. Ivashkin V.T., Maev I.V., Abdulganieva D.I., et al. Practical recommendations of the Scientific Community to promote the clinical study of the human microbiome (NSOIM) and the Russian Gastroenterological Association (RGA) on the diagnosis and treatment of bacterial overgrowth syndrome in adults. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2022;32(3):68–85. (in Russ.). doi: 10.22416/1382-4376-2022-32-3-68-85

44. Kruis W, Meier E, Schumacher M, et al. Randomised clinical trial: mesalazine (Salofalk granules) for uncomplicated diverticular disease of the colon a placebo-controlled study. Aliment Pharmacol Ther. 2013;37(7):680–690. doi: 10.1111/apt.12248

45. Picchio M, Elisei W, Tursi A. Mesalazine to treat symptomatic uncomplicated diverticular disease and to prevent acute diverticulitis occurrence. A systematic review with meta-analysis of randomized, placebo-controlled trials. J Gastrointestin Liver Dis. 2018;27(3):291–297. doi: 10.15403/jgld.2014.1121.273.pic

46. Carter F, Alsayb M, Marshall JK, et al. Mesalamine (5-ASA) for the prevention of recurrent diverticulitis. Cochrane Database Syst Rev. 2017;10(10):CD009839. Published 2017 Oct 3. doi: 10.1002/14651858.CD009839.pub2

47. Rezapour M, Stollman N. Antibiotics in Uncomplicated Acute Diverticulitis: To Give or Not to Give? Inflamm Intest Dis. 2018;3(2):75–79. doi: 10.1159/000489631

48. You H, Sweeny A, Cooper ML, et al. The management of diverticulitis: a review of the guidelines. Med J Aust. 2019;211(9):421–427. doi: 10.5694/mja2.50276

49. Gregersen R, Mortensen LQ, Burcharth J, et al. Treatment of patients with acute colonic diverticulitis complicated by abscess formation: A systematic review. Int J Surg. 2016 Nov;35:201–208. doi: 10.1016/j.ijsu.2016.10.006 Epub 2016 Oct 11.

50. Young-Fadok TM. Diverticulitis [published correction appears in N Engl J Med. 2019 Jan 31;380(5):502]. N Engl J Med. 2018;379(17):1635–1642. doi: 10.1056/NEJMcp1800468

51. Swanson SM, Strate LL. Acute Colonic Diverticulitis [published correction appears in Ann Intern Med. 2020 May 5;172(9):640]. Ann Intern Med. 2018;168(9):ITC65-ITC80. doi: 10.7326/AITC201805010

52. Daniels L, Ünlü Ç, de Korte N, et al. Randomized clinical trial of observational versus antibiotic treatment for a first episode of CT-proven uncomplicated acute diverticulitis. Br J Surg. 2017;104(1):52–61. doi: 10.1002/bjs.10309

53. Desai M, Fathallah J, Nutalapati V, et al. Antibiotics versus no antibiotics for acute uncomplicated diverticulitis: a systematic review and meta-analysis. Dis Colon Rectum. 2019;62(8):1005–1012. doi: 10.1097/DCR.0000000000001324

54. Andeweg CS, Berg R, Staal JB, et al. Patient-reported outcomes after conservative or surgical management of recurrent and chronic complaints of diverticulitis: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2016 Feb;14(2):183–90. doi: 10.1016/j.cgh.2015.08.020 Epub 2015 Aug 21

55. Bianchi M, Festa V, Moretti A, et al. Meta-analysis: longterm therapy with rifaximin in the management of uncomplicated diverticular disease. Aliment Pharmacol Ther. 2011;33:902–910.

56. Tursi A, Brandimarte G, Daffinà R. Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon. Dig Liver Dis. 2002 Jul;34(7):510–5. doi: 10.1016/s1590-8658(02)80110-4 PMID: 12236485.

57. Shelygin Y.A., Achkasov S.I., Moskalev A.I., et al. Colonic-urinary fistulas as a complication of diverticular disease. Urology. 2013;1:17–23. (in Russ.).

58. Galetin T, Galetin A, Vestweber KH, et al. Systematic review and comparison of national and international guidelines on diverticular disease. Int J Colorectal Dis. 2018 Mar;33(3):261–272. doi: 10.1007/s00384-017-2960-z Epub 2018 Jan 18.

59. Cirocchi R, Afshar S, Di Saverio S, et al. A historical review of surgery for peritonitis secondary to acute colonic diverticulitis: from Lockhart-Mummery to evidence-based medicine. World J Emerg Surg. 2017;12:14. Published 2017 Mar 9. doi: 10.1186/s13017-017-0120-y

60. Wu KL, Lee KC, Liu CC, et al. Laparoscopic versus open surgery for diverticulitis: a systematic review and meta-analysis. Dig Surg. 2017;34(3):203–215. doi: 10.1159/000450683

61. Bridoux V, Regimbeau JM, Ouaissi M, et al. Hartmann's procedure or primary anastomosis for generalized peritonitis due to perforated diverticulitis: a prospective multicenter randomized trial (DIVERTI). J Am Coll Surg. 2017;225(6):798–805. doi: 10.1016/j.jamcollsurg.2017.09.004

62. National Guideline Centre (UK). Evidence review for primary versus secondary anastomosis (timing of anastomosis) in complicated acute diverticulitis: Diverticular disease: diagnosis and management. London: National Institute for Health and Care Excellence (UK); 2019.

63. Penna M, Markar SR, Mackenzie H, et al. Laparoscopic lavage versus primary resection for acute perforated diverticulitis: review and meta-analysis. Ann Surg. 2018;267(2):252–258. doi: 10.1097/SLA.0000000000002236

64. Klarenbeek BR, Samuels M, van der Wal MA, et al. Indications for elective sigmoid resection in diverticular disease. Ann Surg. 2010;251(4):670–674.

65. Bolkenstein HE, Consten ECJ, van der Palen J, et al. Long-term outcome of surgery versus conservative management for recurrent and ongoing complaints after an episode of diverticulitis: 5-year follow-up results of a multicenter randomized controlled trial (DIRECT-Trial). Ann Surg. 2019;269(4):612–620. doi: 10.1097/SLA.0000000000003033

66. Melchior S, Cudovic D, Jones J, et al. Diagnosis and surgical management of colovesical fistulas due to sigmoid diverticulitis. J Urol. 2009 Sep;182(3):978–82. doi: 10.1016/j.juro.2009.05.022 Epub 2009 Jul 18.

67. Salamov K.N., Vorobyov G.I., Achkasov S.I., et al. Determination of the boundaries of colon resection in diverticulosis. Surgery. 2001;1:80–86. (in Russ.).

68. Thaler K, Baig MK, Berho M, et al. Determinants of recurrence after sigmoid resection for uncomplicated diverticulitis. Dis Colon Rectum. 2003;46:385–388.

69. Achkasov S.I. Surgical tactics in the rehabilitation treatment of complicated diverticulosis of the colon. Abstract of dissertation of the Candidate of Medical Sciences. M., 1992. 24 p. (in Russ.).

70. Chen CY, Wu CC, Jao SW, et al. Colonic diverticular bleeding with comorbid diseases may need elective colectomy. J Gastrointest Surg. 2009;13(3):516–520. doi: 10.1007/s11605-008-0731-4

71. Aune D, Sen A, Leitzmann MF, et al. Tobacco smoking and the risk of diverticular disease — a systematic review and metaanalysis of prospective studies. Colorectal Dis. 2017;19(7):621–633. doi: 10.1111/codi.13748

72. Spiller RC. Changing views on diverticular disease: impact of aging, obesity, diet, and microbiota. Neurogastroenterol Motil. 2015;27(3):305–312. doi: 10.1111/nmo.12526

73. Strate LL, Liu YL, Syngal S, et al. Nut, corn, and popcorn consumption and the incidence of diverticular disease. JAMA. 2008;300(8):907–914. doi: 10.1001/jama.300.8.907

74. Böhm SK. Risk Factors for Diverticulosis, Diverticulitis, Diverticular Perforation, and Bleeding: A Plea for More Subtle History Taking. Viszeralmedizin. 2015;31(2):84–94. doi: 10.1159/000381867

75. Aune D, Sen A, Leitzmann MF, et al. Body mass index and physical activity and the risk of diverticular disease: a systematic review and meta-analysis of prospective studies. Eur J Nutr. 2017;56(8):2423–2438. doi: 10.1007/s00394-017-1443-x

76. Reichert MC, Lammert F. The genetic epidemiology of diverticulosis and diverticular disease: Emerging evidence. United European Gastroenterol J. 2015;3(5):409–418. doi: 10.1177/2050640615576676

77. Ivashkin V.T., Shelygin Yu.A., Baranskaya E.K., et al. Irritable bowel syndrome. Koloproktologia. 2022;21(1):10–25. (in Russ.). doi: 10.33878/2073-7556-2022-21-1-10-25

78. Mayev I.V., Dicheva D.T., Andreev D.N. Diverticular colon disease. A textbook for doctors. M., 2015. 22 p. (in Russ.).

79. Boitsov S.A., Lazebnik L.B., Levchenko S.V., et al. Rational pharmacotherapy of symptomatic uncomplicated diverticular colon disease. Experimental and clinical gastroenterology. 2018;(5):86–92. (in Russ.).

80. Yakovenko E.P., Yakovenko A.V., Agafonova N.A., et al. Abdominal pain: Mechanisms of formation, a rational approach to the choice of therapy. RMJ. 2009;11(2):48–53. (in Russ.).


Review

For citations:


Shelygin Yu.A., Ivashkin V.T., Achkasov S.I., Moskalev A.I., Тimerbulatov V.M., Sazhin A.V., Shapovalyants S.G., Karpukhin O.Y., Kostenko N.V., Кorotkikh N.N., Zarodnyuk I.V., Trubacheva J.L., Veselov V.V., Likutov A.A., Kashnikov V.N., Frolov S.A., Yartsev P.A., Loranskaya I.D., Vykova B.A., Shifrin O.S., Poluektova E.A., Mamieva Z.A., Ulyanin A.I., Shkurko T.V. CLINICAL GUIDELINES Diverticular disease (57.2, 57.3), adults. Koloproktologia. 2024;23(2):10-27. https://doi.org/10.33878/2073-7556-2024-23-2-10-27

Views: 8879


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2073-7556 (Print)
ISSN 2686-7303 (Online)